Home › Funds › Nippon Life Global Investors Americas, Inc. › BIIB
Nippon Life Global Investors Americas, Inc. position in BIIB
BIOGEN INC · Health Care
Nippon Life Global Investors Americas, Inc. reported holding 132,210 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$29.9M, representing 1.19% of its reported portfolio and ranking #27 among its reported holdings. Nippon Life Global Investors Americas, Inc. has disclosed BIIB holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Nippon Life Global Investors Americas, Inc.'s BIIB position evolved
Nippon Life Global Investors Americas, Inc. first disclosed a stake in BIIB in Q3 2023 at 6,630 shares (US$1.7M). The position peaked in Q3 2026 at 132,210 shares, worth US$29.9M. Across 6 filings, Nippon Life Global Investors Americas, Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 132,210 shares valued at US$29.9M — a reduction of -5,010 shares quarter over quarter.. Notable position changes include a 27% increase in Q1 2026 (shares rose 18% over the following quarter), a 309% increase in Q2 2026 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.63K | $1.70M | New |
| Q4 2023 | 6.63K | $1.72M | Hold |
| Q4 2025 | 26.49K | $4.66M | New |
| Q1 2026 | 33.57K | $6.15M | Add |
| Q2 2026 | 137.22K | $29.65M | Add |
| Q3 2026 | 132.21K | $29.86M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIIB and 13F data
BIIB (BIOGEN INC) is a Health Care company. 20 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.43B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIIB
- PRIMECAP MANAGEMENT CO/CA/ 15.20M sh · $3.43B · Q3 2026
More on Nippon Life Global Investors Americas, Inc.
FAQ
How long has Nippon Life Global Investors Americas, Inc. held BIIB?
Nippon Life Global Investors Americas, Inc. has disclosed BIIB holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
What is Nippon Life Global Investors Americas, Inc.'s current position in BIIB?
As of Q3 2026, Nippon Life Global Investors Americas, Inc. holds 132.21K shares of BIIB (BIOGEN INC), valued at $29.86M, representing 1.19% of its reported portfolio and ranking #27.
Has Nippon Life Global Investors Americas, Inc. been buying or selling BIIB?
In the latest 13F filing (Q3 2026), Nippon Life Global Investors Americas, Inc. reduced its position in BIIB. The position peaked in Q3 2026 at 132.21K shares.
Which other funds hold BIIB?
Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.